News

XiFin, Inc. Achieves Sixth Consecutive #1 Client Experience Rating in Laboratory and Ancillary Revenue Cycle Services, Black Book Survey

TAMPA, FL / ACCESSWIRE / November 12, 2024 / Black Book Research has announced the leading comprehensive revenue cycle management…

1 year ago

Moderna Tops BioSpace’s Best Places to Work Ranking for Fourth Consecutive Year

CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one…

1 year ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,…

1 year ago

Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara

McNamara's extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise…

1 year ago

Quest Responds to the Surge in FDA Recalls by Strengthening Industry-Leading Field Corrective Action Services

Quest International's Expanded FCA Resources Offer Medical Device OEMs Timely, Reliable Support Amid Rising FDA RecallsIRVINE, CA / ACCESSWIRE /…

1 year ago

Noble Capital Markets Initiates Equity Research Coverage on Zomedica

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care…

1 year ago

FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression

Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective TreatmentMINNEAPOLIS and CARMARTHENSHIRE, United Kingdom,…

1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) --…

1 year ago

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents…

1 year ago

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025INDIANAPOLIS and FLORHAM PARK, N.J.,…

1 year ago